HRT Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History

HRT Financial’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$459K	Buy
2022 Q2	–	Sell
2022 Q1	$282K	Buy
2020 Q1	–	Sell
2019 Q4	$265K	Buy